ARCHIVES

NCI R01 Payline Falls To 12th Percentile In Fifth Year Of No-Growth Budgets.

This article is from The Cancer Letter archive.

Vol. 34 No. 09 | March 7, 2008

Download PDF Visit The Full Archive

Related Articles

Walter Reed Oncologic Pharmacy Residency Program Has Openings

November 25, 1988

House Members Who Voted for Veto

January 3, 1986

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

In Brief: Cancer Act renewal, Appropriations Bill Caught In Squeeze Between Conventions

August 1, 1980

Letter to the Editor: NCI Should Continue Supporting Research In Special Populations

July 31, 1998

“Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising.

May 18, 2007